By Kate O’Rourke
Optoacoustic technology fused with ultrasound imaging looks promising to improve breast cancer diagnosis, by differentiating between benign and malignant breast masses and among subtypes of breast cancer, according to studies presented at recent medical conventions.
Breast mass identification can be difficult with current technology, often resorting to a needle biopsy for further examination, said Stephen Grobmyer, MD, the co-leader of the Cleveland Clinic’s